The potential of cystatin C as a predictive biomarker in breast cancer

Gaetano Leto, Maria Vittoria Sepporta

Risultato della ricerca: Articlepeer review


Breast cancer (BCa) is the leading cause of cancer-related deaths among women. Numerous efforts are being directed toward identifying novel tissue and/or circulating molecular markers that may help clinicians in detecting early-stage BCa patients and in providing an accurate estimation of the prognosis and prediction of response to clinical treatments. In this setting, emerging evidence has indicated Cystatin C (Cyst C), as the most potent endogenous inhibitor of cysteine cathepsins, as a possible useful marker in the clinical management of BCa patients.
Lingua originaleEnglish
pagine (da-a)1-8-8
Numero di pagine9
RivistaExpert Review of Anticancer Therapy
Stato di pubblicazionePublished - 2020

Cita questo